Representative before the EPO

Employment test 1 - 10 employees
Company dna avidity ip ltd
no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services

Representative before the EPO

Employment test 1 - 10 employees
Company dna park grove ip ltd
operating since 2014
Headquarter in Nottingham
active in Legal Services and IP Consulting

Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 53 EP applications Michael D. Snodin has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11715112

POLYCYCLIC TETRACYCLINE COMPOUNDS

IPC classification:
A61P 31/00, C07D 209/58, C07D 221/18, C07D 243/10, C07D 405/04, C07D 405/06, C07D 487/04, A61K 31/403, A61K 31/473, A61K 31/551
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
PATENT GRANTED
EP11716163

CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUNDS AND A EGFR INHIBITOR

IPC classification:
A61P 35/00, A61K 31/4196, A61K 31/675
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11725836

CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUND AND A TOPOISOMERASE II INHIBITOR

IPC classification:
A61P 35/00, A61K 31/404, A61K 31/4196, A61K 31/423, A61K 31/7004, A61K 45/06
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11709273

THIOXANTHONE-BASED AUTOPHAGY INHIBITOR THERAPIES TO TREAT CANCER

IPC classification:
A61K 31/00, A61K 31/138, A61K 31/165, A61K 31/166, A61K 31/167, A61K 31/18, A61K 31/19, A61K 31/222, A61K 31/337, A61K 31/343, A61K 31/382, A61K 31/39, A61K 31/404, A61K 31/7004, A61K 33/36
Agent:
Michael D. Snodin, Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP12190876

Catalyst compositions for conversion of vegetable oils to hydrocarbon products in the diesel boiling range and process of preparation thereof

IPC classification:
B01J 23/652, B01J 23/85, B01J 27/188
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11781405

COMPOSITIONS AND METHODS FOR MODULATING METABOLISM

IPC classification:
A61P 1/16, A61P 3/04, A61P 3/06, A61P 3/10, A61P 9/10, A61P 9/12, C12N 15/09, A61K 31/00, A61K 31/5517, A61K 31/69, A61K 31/713
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP11781410

MALE CONTRACEPTIVE COMPOSITIONS AND METHODS OF USE

IPC classification:
A61P 15/00, C07D 471/00, C07D 495/14, A61K 31/5517
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
Baylor College of Medicine
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP11719114

USE OF BIS [THIOHYDRAZIDE AMIDE]COMPOUNDS SUCH AS ELESCLOMOL FOR TREATING CANCERS

IPC classification:
A61P 35/00, A61P 35/02, A61K 31/00, A61K 31/18, A61K 31/195, A61K 31/337, A61K 31/555
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12719030

INTERPENETRATING DILATANT POLYMER NETWORK FOR IMPACT PROTECTION

IPC classification:
C08G 18/61, C08G 77/458, C08G 77/56, F41H 5/06
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
GRANT OF PATENT INTENDED
EP12720343

PROCESS FOR LATEX PRODUCTION BY MELT EMULSIFICATION

IPC classification:
C08J 3/05, C09D 167/04
Agent:
Michael D. Snodin, Potter Clarkson LLP
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION IN PROGRESS
EP11186691

Renin Inhibitors

IPC classification:
A61P 9/00, C07D 211/22, C07D 211/26, C07D 401/12, C07D 405/12, C07D 407/12, C07D 409/06, C07D 417/06, A61K 31/445, A61K 31/453
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12748817

POST PROCESS PURIFICATION FOR GAMMA-BUTYROLACTONE PRODUCTION

IPC classification:
B01D 3/00, B01D 3/14, C07D 307/33, C12P 7/62
Agent:
Michael D. Snodin, Potter Clarkson LLP
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12827951

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A01N 35/00, A61K 31/12
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12831538

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
C07D 241/36, A61K 31/498
Applicant:
Neupharma, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12757740

COMPOSITIONS, PROCESS OF PREPARATION OF SAID COMPOSITIONS AND METHOD OF TREATING INFLAMMATORY DISEASES

IPC classification:
A61P 19/02, A61P 29/00, C12N 15/09, A61K 31/366, A61K 31/506, A61K 31/519, A61K 45/06
Agent:
Michael D. Snodin, Avidity IP Ltd
Agent:
David Alcock, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11751491

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

IPC classification:
C07D 203/04, C07D 203/06, C07D 207/337, C07D 231/12, C07D 233/64, C07D 249/08, C07D 257/04, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/06, C07D 403/12, C07D 405/12, C07D 417/04, C07D 417/12
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
PATENT GRANTED
EP12787341

MACROCYCLIC COMPOUNDS FOR INHIBITION OF INHIBITORS OF APOPTOSIS

IPC classification:
A61P 35/00, C07D 249/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12849310

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 31/4412
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12850561

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 31/4412
Agent:
Multiple attorneys, Avidity IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12816935

COMPOSITIONS, PROCESS OF PREPARATION OF SAID COMPOSITIONS AND METHOD OF TREATING INFLAMMATORY DISEASES

IPC classification:
A61P 19/02, A61P 29/00, A61K 9/00, A61K 31/4178, A61K 31/44, A61K 31/50, A61K 45/06
Agent:
Michael D. Snodin, Avidity IP Ltd
Agent:
David Alcock, D Young & Co LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13710245

GENETICALLY ENGINEERED MICROORGANISMS FOR THE PRODUCTION OF POLY-4-HYDROXYBUTYRATE

IPC classification:
C12N 1/21, C12N 9/00, C12N 9/02, C12N 9/04, C12N 9/12, C12N 9/88, C12P 7/62
Agent:
Michael D. Snodin, Potter Clarkson LLP
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION IN PROGRESS
EP12833985

CERTAIN CHEMICAL ENTITES, COMPOSITIONS, AND METHODS

IPC classification:
A61P 35/00, C07D 241/42, A61K 31/498
Applicant:
Neupharma, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13729223

BIOBASED RUBBER MODIFIED BIODEGRADABLE POLYMER BLENDS

IPC classification:
C08J 3/24, C08L 67/04
Agent:
Michael D. Snodin, Potter Clarkson LLP
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13732046

DEUTERATED DERIVATIVES OF RUXOLITINIB

IPC classification:
A61P 35/02, C07B 59/00, C07D 487/04, A61K 31/519
Applicant:
Concert Pharmaceuticals Inc
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION IN PROGRESS
EP13740167

DEUTERATED IDEBENONE

IPC classification:
C07B 59/00, C07C 50/28
Applicant:
Concert Pharmaceuticals Inc
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13805698

SUBSTITUTED 2,3-DIHYDROBENZOFURANYL COMPOUNDS AND USES THEREOF

IPC classification:
A61P 35/00, C07D 405/12, C07D 405/14, C07D 409/14, A61K 31/4427
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
GRANT OF PATENT INTENDED
EP13818142

TRANSCRIPTIONAL REGULATION FOR IMPROVED PLANT PRODUCTIVITY

IPC classification:
C07K 14/415, C12N 15/82
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION IN PROGRESS
EP14720403

METHODS OF PROMOTING WOUND HEALING USING CRM1 INHIBITORS

IPC classification:
A61P 17/02, C07D 403/12, A61K 31/4196, A61K 31/497, A61K 31/506
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION REQUESTED
EP14758641

PHOSPHOHISTIDINE AND PHOSPHOTYROSINE ANALOGUES

IPC classification:
C07F 9/58, C07F 9/6503, C07F 9/6539, C07F 9/6553, C07K 16/44
Applicant:
University of Sheffield
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
PATENT GRANTED
EP14715106

KINASE INHIBITOR

IPC classification:
A61P 29/00, C07C 311/08, C07D 239/47, A61K 31/505
Applicant:
Respivert Ltd
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION IN PROGRESS
EP11709452

TRIAZOLO [4, 5 - B]PYRIDIN DERIVATIVES

IPC classification:
A61P 9/10, A61P 19/02, A61P 25/28, A61P 29/00, A61P 31/12, A61P 33/00, A61P 35/00, C07D 471/04, A61K 31/4192, A61K 31/437
Applicant:
Centro Nacional de Investigaciones Oncológicas (CNIO)
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15748095

ADJUSTABLE ENDOLUMENAL MITRAL VALVE RING

IPC classification:
A61B 17/064, A61F 2/24
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION REQUESTED
EP14720799

SYSTEMS AND METHODS FOR RESHAPING A HEART VALVE

IPC classification:
A61F 2/24
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION IN PROGRESS
EP11776958

PHARMACEUTICAL FORMULATION FOR HISTONE DEACETYLASE INHIBITORS

IPC classification:
A61P 17/00, A61P 35/00, A61K 9/06, A61K 31/165, A61K 47/02, A61K 47/10, A61K 47/12, A61K 47/14, A61K 47/38
Agent:
Simon Mark Wright, J A Kemp
Agent:
Michael D. Snodin, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP14733030

RECYCLATE BLENDS

IPC classification:
C08J 11/04, C08L 27/06, C08L 101/00
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11704571

1,2,4-TRIAZINE-4-AMINE DERIVATIVES

IPC classification:
C07D 253/07, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/12, C07D 405/04, C07D 405/10, C07D 413/04, C07D 417/12, C07D 487/04, A61K 31/53
Agent:
Multiple attorneys, Potter Clarkson LLP
Agent:
Teyrnon Cei Jones, AstraZeneca AB
Agent:
Teyrnon Cei Jones, AstraZeneca PLC
Agent:
Stratagem IPM Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14738998

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

IPC classification:
A61P 35/00, C07D 249/08, A61K 31/497
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION IN PROGRESS
EP14742127

SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF

IPC classification:
A61P 35/00, C07D 307/81, C07D 405/12, C07D 405/14, C07D 409/14, C07D 413/12, C07D 417/12, A61K 31/4427
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
GRANT OF PATENT INTENDED
EP11781299

THERAPEUTIC REGIMENS

IPC classification:
A61P 5/24, A61K 31/137
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11760643

HSP90 INHIBITORS FOR TREATING NON-SMALL CELL LUNG CANCERS IN WILD-TYPE EGFR AND/OR KRAS PATIENTS

IPC classification:
A61P 35/00, A61K 31/404, A61K 31/4196, A61K 31/423, A61K 45/06
Applicant:
Synta Pharmaceuticals Corp.
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14790829

INHIBITION OF SGK1 IN THE TREATMENT OF HEART CONDITIONS

IPC classification:
A61P 9/06, A61K 31/513, A61K 38/00, A61K 39/00
Applicant:
Beth Israel Deaconess Medical Center Inc
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
GRANT OF PATENT INTENDED
EP11767355

SELECTIVE ANDROGEN RECEPTOR MODULATORS

IPC classification:
A61P 19/10, C07D 207/26, C07D 233/36, C07D 263/24, C07D 417/04, A61K 31/402, A61K 31/4166, A61K 31/421
Agent:
Michael D. Snodin, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14868547

CROSS-LINKED PEG POLYMER COATING FOR IMPROVING BIOCOMPATIBILITY OF MEDICAL DEVICES

IPC classification:
B05D 1/02
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION REQUESTED
EP11740437

SELECTIVE ANDROGEN RECEPTOR MODULATORS

IPC classification:
A61P 9/00, A61P 35/00, C07D 209/88, A61K 31/403
Agent:
Multiple attorneys, Potter Clarkson LLP
Status:
PATENT GRANTED
EP11708606

PROCESS FOR PRODUCING A LOWER ALKYL ACRYLATE AND 2-BUTENE FROM A GENETICALLY MODIFIED POLY-3-HYDROXYBUTYRATE BIOMASS

IPC classification:
C07C 67/08, C07C 67/333, C07C 69/54, C07C 69/56, C07D 305/12, C07D 307/33, C07D 309/30, C07D 319/12, C07D 407/04, C12P 7/52, C12P 7/62, C12P 17/04, A45D 40/00
Agent:
Multiple attorneys, Potter Clarkson LLP
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
The patent has been granted
EP15710997

TREATMENT OF CONDITIONS ASSOCIATED WITH HYPERINSULINAEMIA

IPC classification:
A61P 35/00, A61K 31/5517
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION REQUESTED
EP11706979

PROCESS FOR GAMMA-BUTYROLACTONE PRODUCTION

IPC classification:
C07D 305/12, C07D 307/33, C07D 309/30, C07D 319/12, C07D 407/04, C12P 7/52, C12P 7/62, C12P 17/04, A45D 40/00
Agent:
Multiple attorneys, Potter Clarkson LLP
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15716318

HIGHLY FILLED POLYMER SYSTEMS

IPC classification:
C08K 3/26, C08K 3/34, C08L 27/06, C08L 67/04
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION REQUESTED
EP15727132

ORGANIC LIGHT-EMITTING DIODE MATERIALS

IPC classification:
C09K 11/06, H01L 33/00
Applicant:
Harvard College
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION REQUESTED
EP15754099

POLYMORPHS OF SELINEXOR

IPC classification:
A61P 25/00, A61P 31/00, A61P 35/00, C07D 403/12, A61K 31/497
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
EXAMINATION REQUESTED
EP15782018

4-(4-(4-PHENYLUREIDO-NAPHTHALEN-1-YL)OXY-PYRIDIN-2-YL)AMINO-BENZOIC ACID DERIVATIVE AS P38 KINASE INHIBITOR

IPC classification:
A61P 29/00, C07D 213/74, A61K 31/44
Applicant:
Respivert Ltd
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
Request for examination was made
EP15791440

SEMI-SYNTHESIS PROCEDURES

IPC classification:
C07C 231/12, C07C 237/26, C07C 245/20, C07D 207/06
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
Request for examination was made
EP15791448

BROMODOMAIN INHIBITORS

IPC classification:
A61P 3/00, A61P 9/00, A61P 15/16, A61P 29/00, A61P 31/00, A61P 33/06, A61P 35/00, A61P 35/02, C07D 495/14, A61K 31/551
Agent:
Michael D. Snodin, Park Grove IP Ltd
Status:
Request for examination was made

Please Sign in to use this feature